Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of $0.00 per share and revenue of $513.66 million for the quarter.
Aveanna Healthcare Stock Performance
Shares of Aveanna Healthcare stock traded up $0.05 on Tuesday, hitting $4.79. The company had a trading volume of 347,401 shares, compared to its average volume of 261,837. The stock has a 50 day moving average of $4.77 and a 200-day moving average of $4.89. Aveanna Healthcare has a 1 year low of $2.31 and a 1 year high of $6.19. The stock has a market capitalization of $935.09 million, a price-to-earnings ratio of -14.10 and a beta of 2.01.
Insider Activity at Aveanna Healthcare
In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total value of $31,415.40. Following the completion of the sale, the insider now owns 1,451,598 shares of the company's stock, valued at approximately $8,172,496.74. The trade was a 0.38 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In the last three months, insiders have sold 67,412 shares of company stock valued at $372,142. 7.80% of the stock is owned by corporate insiders.
Analyst Ratings Changes
AVAH has been the topic of several research analyst reports. UBS Group upped their price objective on Aveanna Healthcare from $3.20 to $4.50 and gave the company a "sell" rating in a research note on Friday, March 14th. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a research note on Friday, April 11th.
Check Out Our Latest Stock Analysis on Aveanna Healthcare
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Recommended Stories
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
